InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Robichaud Albert, Directeur Scientifique. Officer active across 1 companies, notably Sage Therapeutics, Inc.. Cumulatively, 4 reports have been published. The latest transaction was disclosed on 19 October 2021 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations4 total
03,800 shares0
Common Stock
SEC:0001562180-21-006599·
03,800 shares0
Common Stock
SEC:0001562180-21-006599:0·
04,000 shares0
Common Stock
SEC:0001562180-21-004339·
04,000 shares0
Common Stock
SEC:0001562180-21-004339:0·
4 of 4 declarations
About Robichaud Albert
Albert Robichaud is the Chief Scientific Officer at Sage Therapeutics, Inc. He is responsible for leading research and development initiatives, playing a key role in the innovation and advancement of the company's products.
